Within a modern study, we noted the identification as well as the characterization of a whole new atypical opioid receptor with exceptional adverse regulatory Houses in the direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be a wid